BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 8886063)

  • 1. Potassium-titanyl-phosphate laser vaporization of the prostate: a comparative functional and pathologic study in canines.
    Kuntzman RS; Malek RS; Barrett DM; Bostwick DG
    Urology; 1996 Oct; 48(4):575-83. PubMed ID: 8886063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-power (60-watt) potassium-titanyl-phosphate laser vaporization prostatectomy in living canines and in human and canine cadavers.
    Kuntzman RS; Malek RS; Barrett DM; Bostwick DG
    Urology; 1997 May; 49(5):703-8. PubMed ID: 9145974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laser prostatectomy: two and a half years' experience with aggressive multifocal therapy.
    Kollmorgen TA; Malek RS; Barrett DM
    Urology; 1996 Aug; 48(2):217-22. PubMed ID: 8753732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-power potassium titanyl phosphate laser vaporization prostatectomy.
    Kuntzman RS; Malek RS; Barrett DM
    Mayo Clin Proc; 1998 Aug; 73(8):798-801. PubMed ID: 9703311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Holmium: YAG laser prostatectomy canine feasibility study.
    Kabalin JN
    Lasers Surg Med; 1996; 18(3):221-4. PubMed ID: 8778515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High power potassium-titanyl-phosphate laser vaporization prostatectomy.
    Malek RS; Kuntzman RS; Barrett DM
    J Urol; 2000 Jun; 163(6):1730-3. PubMed ID: 10799170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insight into mechanism of neodymium: yttrium-aluminum-garnet laser prostatectomy utilizing the high-power contact-free beam technique.
    Kabalin JN; Gong M; Issa MM; Sellers R
    Urology; 1995 Mar; 45(3):421-6. PubMed ID: 7879334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short term outcomes of high power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate.
    Volkan T; Ihsan TA; Yilmaz O; Emin O; Selcuk S; Koray K; Bedi O
    Eur Urol; 2005 Oct; 48(4):608-13. PubMed ID: 16135396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photoselective vaporization of the prostate using a laser high performance system in the canine model.
    Lee R; Saini R; Zoltan E; Te AE
    J Urol; 2008 Oct; 180(4):1551-3. PubMed ID: 18710776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The KTP-(greenlight-) laser--principles and experiences.
    Bachmann A; Ruszat R
    Minim Invasive Ther Allied Technol; 2007; 16(1):5-10. PubMed ID: 17365672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaporization of prostates of > or =80 mL using a potassium-titanyl-phosphate laser: midterm-results and comparison with prostates of <80 mL.
    Pfitzenmaier J; Gilfrich C; Pritsch M; Herrmann D; Buse S; Haferkamp A; Djakovic N; Pahernik S; Hohenfellner M
    BJU Int; 2008 Aug; 102(3):322-7. PubMed ID: 18422772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual laser ablation of the canine prostate with a diffusing fiber and an 805-nanometer diode laser.
    Cromeens DM; Johnson DE; Stephens LC; Gray KN
    Lasers Surg Med; 1996; 19(2):135-42. PubMed ID: 8887915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-power potassium-titanyl-phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates.
    Sandhu JS; Ng C; Vanderbrink BA; Egan C; Kaplan SA; Te AE
    Urology; 2004 Dec; 64(6):1155-9. PubMed ID: 15596189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients.
    Reich O; Bachmann A; Siebels M; Hofstetter A; Stief CG; Sulser T
    J Urol; 2005 Jan; 173(1):158-60. PubMed ID: 15592063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current role of lasers in the treatment of benign prostatic hyperplasia (BPH).
    Kuntz RM
    Eur Urol; 2006 Jun; 49(6):961-9. PubMed ID: 16632179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years.
    Te AE; Malloy TR; Stein BS; Ulchaker JC; Nseyo UO; Hai MA
    BJU Int; 2006 Jun; 97(6):1229-33. PubMed ID: 16686717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laser vaporization of bovine prostate: a quantitative comparison of potassium-titanyl-phosphate and lithium triborate lasers.
    Kang HW; Jebens D; Malek RS; Mitchell G; Koullick E
    J Urol; 2008 Dec; 180(6):2675-80. PubMed ID: 18951570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photoselective vaporization of the prostate: a volume reduction analysis in patients with lower urinary tract symptoms secondary to benign prostatic hyperplasia and carcinoma of the prostate.
    Kumar SM
    J Urol; 2005 Feb; 173(2):511-3. PubMed ID: 15643231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Greenlight photoselective 120-watt 532-nm lithium triborate laser vaporization prostatectomy in living canines.
    Malek RS; Kang HW; Coad JE; Koullick E
    J Endourol; 2009 May; 23(5):837-45. PubMed ID: 19371169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of expired breath ethanol measurements in evaluation of irrigant absorption during high-power potassium titanyl phosphate laser vaporization of prostate.
    Barber NJ; Zhu G; Donohue JF; Thompson PM; Walsh K; Muir GH
    Urology; 2006 Jan; 67(1):80-3. PubMed ID: 16413337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.